67-4

34/90

nylureas or insulin compared with conventional treat-ment and risk of complications in patients type 2 diabetes (UKPDS33). Lancet, 1998; 352: 837-853. 8) Ueki K, Sasako T, Okazaki Y, et al: Effect of an intensi-fied multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial Lancet Diabetes Endocrinol, 2017; 5: 951-964. 9) E. Erdmann: Microalbuminuria as a marker of cardio-vascular risk in patients with type 2 diabetes, 2006; 107: 147-153.10) Adrienne A.M. Zandbergen, MD, PHD1, Liffert Vogt, MD2, Dick de Zeeuw, MD, PHD2, et al: Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients with Type 2 Diabetes and Microalbuminuria. Diabetes Care, 2007; 30: 3119-3121.11) Viazzi F. Greco E. Ceriello A. et al: Apparent Treat-ment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes. Kidney Blood Press Res, 2018; 43: 422-438.12) Nobue Tanaka, Tetsuya Babazono, Michino Takagi, et al: Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients: Nephrology (Carlton), 2015; 20: 531-538.13) Yi-Jing Sheen, Jiann-Liang Lin, Tsai-chung Li, et al: Systolic blood pressure as a predictor of incident albu-minuria and rapid renal function decline in type 2 diabetic patients. Journal of Diabetes and Its Complica-tions, 2014; 28: 779-784.14) Menne, Jan Izzo Joseph L. Jr Ito, Sadayoshi et al: Prevention of microalbuminuria in patients with type 2 diabetes and hypertension. Journal of Hypertension, 2012; 30: 811-818.15) Muhammad Usman, Clare L Gillies, Kamiesh Khunti and Melanie H Davies: Effects of intensive interven-tions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials: Diabetes Research and Clinical Practice, 2018; 146: 76-84.16) Juha Varis, Kaj Mesarinne, Veikko Koivisto et al: Improved control of blood pressure and albuminuria among patients with type-2 diabetes in Finnish open 354care: Blood Press, 2017; 26: 67-73.17) Henri Afghahi, Jan Cederholm, Bjorn Eliasson et al: Risk factors for the development of albuminuria and renal impairment in type 2 diabetes—the Swedish National Diabetes Register (NDR): Nephrology Dial-ysis Transplantation, 2011; 26: 1236-1243.18) C. Bianchi, G. Penno, G. Daniele, et al: The metabolic syndrome is related to albuminuria in Type 2 diabetes: Diabet Med, 2008; 25: 1412-1418.19) Anwar Ali Showail, Medhat Ghoraba: The association between glycemic control and microalbuminuria in Type 2 diabetes: Saudi Kidney Dis Transpl, 2016; 27: 473-479. 20) M Takagi, T Babazono, Y Uchigata: Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease: Diabet Med, 2015; 32: 1354-1360.21) Min-Kyung Lee, Kyung-Do Han, Jae-Hyuk Lee, et al: Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes: Sci Rep, 2017; 7: 11757.22) Thilak Weerarathna, Gayani Liyanage, Meththananda Herath et al: Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardio-vascular Disease: Biomed Res Int, 2018; 26: 8178043.23) D.R. Webb, F. Zaccardi, M.J. Davies, et al: Cardiovas-cular risk factors and incident albuminuria in screen‐detected type 2 diabetes: Ciabetes Metab Res Rev, 2017; 33: 2877.24) Ravi Retnakaran, Carole A. Cull, Kerensa I. Thorne, et al. the UKPDS Study Group: Risk Factors for Renal Dysfunction in Type 2 Diabetes U.K. Prospective Diabetes Study 74: Diabetes, 2006; 55: 1832-1839.25) Yasuho Shimada, Yasuto Nakasone, Kazuko Hiraba-yashi, et al: Development of glomerular hyperfiltration, a multiphasic phenomenon: Renal physiol, 2020; 319: 1037-1041.26) Lennart Tonneijck, Marcel H.A. Muskiet, Mark M. Smits, et al: Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment: Soc Nephrol, 2017; 28: 1023-1039.